Centre for Pharmaceutical Chemistry
ABOUT US
Welcome to the Centre for Pharmaceutical Chemistry & Analysis!
Exploring Nature's Toolkit: Medicinal Chemistry for Tomorrow's Cures
Centre for Pharmaceutical Chemistry & Analysis provides education in Pharmaceutical Chemistry at undergraduate, postgraduate, and doctoral levels. Our program is meticulously aligned with PCI regulations to equip the students with up-to-date knowledge in pharmaceutical organic, medicinal, and analytical chemistry. Our dedicated faculties are committed to fostering quality education in Pharmaceutical Chemistry and Analysis through our emphasis on teaching, scholarly pursuits, and community engagement.
At our centre, students benefit from a diverse range of educational opportunities, including hands-on involvement in cutting-edge research projects led by our esteemed faculty. We specialize in emerging fields such as Drug Design and Development, Analysis of natural and synthetic products using sophisticated instruments, research writing, and analytical documentation.
Our faculty excels in custom synthesis of small heterocycles and new chemical entities (NCEs), as well as expertise in Ligand and Structure-based Drug Design, in silico virtual screening, and various molecular modelling techniques. Our research endeavours focus on Structure-based approaches to discovering wide therapeutic areas.
The vision & mission of the department are
Vision:
"To be a leader in advancing knowledge within emerging fields such as target-based drug design, custom synthesis and pharmaceutical analysis."
Mission:
"Our mission is to excel in Hit to Lead and Lead Optimization strategies, and to innovate in the development of processes for synthesizing and analysing drugs and drug intermediates."
PROGRAMS OFFERED
- M.Pharm (Pharmaceutical Chemistry)
- M.Pharm (Pharmaceutical Analysis)
ONGOING PROJECTS
Currently Funded Research Projects
Currently we have the below two projects and several are under review and pipeline
| # | Name of the Investigator | Project No. | Funding Agency | Title of the project and duration | Sanctioned Amount (in Rs.) |
| 1 | Dr. Annie Gupta | 2655 | Council of Science and Technology, UP | Metabolomics based bioprospection of medicinal weed plant-Achyranthus aspera in search of elite chemotype in Uttar Pradesh | 13,00,000 |
| 2 | Dr. Puneet Gupta | 3-52/2022-CCRUM/Tech | CCRUM Ministry of AYUSH | Formulation Development and preclinical evaluation of novel Unani dispersible tablets for immunomodulatory activity and as adjuvant to Anticancer therapy | 30,53,690 |
Consultancy Activities
|
Sl. No |
Name of the Study |
Year |
Sponsoring agent |
Amount in Lakhs |
Status |
|
NA |
NA |
NA |
NA |
NA |
NA |
RESEARCH SCHOLARS
|
No. |
Name of Scholar |
Programme |
Date of Registration |
Guide |
Research Title / Topic |
Current Status |
|
2 |
Ms Sonu Sharma |
Ph.D (Pharmaceutical Sciences) |
13-Jul-18 |
Dr. Viney Lather |
Development Of Nanoformulation Of Anti-Oxidant Phytoconstituent For The Treatment Of Neurological Disorder |
Degree Awarded |
|
3 |
Mr Shobhit Mishra |
Ph.D (Pharmaceutical Sciences) |
13-Jul-18 |
Dr. Hemlata Nimesh |
Design, Synthesis & Evaluation Of Novel Hybrid Molecules As Anticancer Agents |
Ongoing |
|
4 |
Mr Gourav Goyal |
Ph.D (Pharmaceutical Sciences) |
19-Jul-19 |
Dr. Viney Lather |
Targetting Signalling Pathways In Autoimmune Disorders Using A Therapeutic Repositing Appoach |
PrePhD done |
|
5 |
Ms Komal Chaudhary |
Ph.D (Pharmaceutical Sciences) |
24-Jan-20 |
Dr. Ramanpreet Walia |
Method Development & Validation Of Anti-Diabetic & Anti-Obesity Formulations Using Modern Analytical Techniques. |
DRC recommended for PrePhD |
|
6 |
Ms Bhawna Arora |
Ph.D (Pharmaceutical Sciences) |
24-Jan-20 |
Dr. Ramanpreet Walia |
Solubility And Bioactivity Enhancement Of Hesperidin And Naringenin. |
DRC recommended for PrePhD |
|
7 |
Mr Hitesh Kumar Sharma |
Ph.D (Pharmaceutical Sciences) |
04-Sep-20 |
Dr. Viney Lather |
Screening And Evaluation Of Phytomolecules In Combination With Antibiotics For Activity Against Multi Drug Resistant Bacteria. |
PrePhD done |
|
8 |
Ms Shivali Rahi |
Ph.D (Pharmaceutical Sciences) |
30-Jul-21 |
Dr. Viney Lather |
Global Drug Regulatory Approval Process Of Artificial Intelligence-Based Medical Devices: Current Status And Future Prospectives. |
ongoing |
|
9 |
Ms Neeti Mishra |
Ph.D (Pharmaceutical Sciences) |
30-Jul-21 |
Dr. Ramanpreet Walia |
Solubility And Bioavailability Enhancement Of Some Important Polyphenols By Chemical Modifications. |
ongoing |
|
10 |
Mr Purshotam |
Ph.D (Pharmaceutical Sciences) |
29-Jan-22 |
Dr. Viney Lather |
Screening And Evaluation Of Phyto-Molecules As Multi-Target Ligands For Alzheimer Disease |
ongoing |
|
11 |
Mr Nilay Kumar Nandi |
Ph.D (Pharmaceutical Sciences) |
18-Sep-23 |
Dr. Viney Lather |
Design And Synthesis Of Novel Monoamine Oxidase Inhibitors As Potential Anti-Depressant Agents |
ongoing |
|
12 |
Ms Afreen N |
Ph.D (Pharmaceutical Sciences) |
18-Sep-23 |
Dr. Smriti Sharma |
Design, Synthesis And Evaluation Of Nitrofuran Derivatives As Anti-Tubercular Agents |
ongoing |
|
13 |
Ms TANYA BANSAL |
Ph.D (Pharmaceutical Sciences) |
09-Feb-24 |
Dr. Puneet Gupta |
To Be Approved By The URC |
ongoing |
|
14 |
Mr Neeraj Kumar |
Ph.D (Pharmaceutical Sciences) |
04-Feb-14 |
Dr. Amrish Chandra |
Improving Drug Release Of Poorly Soluble Drug For Oral Delivery |
Degree Awarded |
|
15 |
Mr Ramji Rathod |
Ph.D (Pharmaceutical Sciences) |
16-Jul-15 |
Dr. Amrish Chandra |
Method Development And Validation Of New Anti Dibetic Class DPP-4 Inhibitor Drugs By LC-MS/MS |
cancellation |
|
16 |
Mr Rishi Kumar |
Ph.D (Pharmaceutical Sciences) |
16-Jan-16 |
Dr. Amrish Chandra |
Stanardization And Formulation Of Ayurvedic Formulation Inot Tablet Dosage Forms |
ODC done |
|
17 |
Ms Ekta |
Ph.D (Pharmaceutical Sciences) |
24-Jan-20 |
Dr. Archana Sharma |
Development And Evaluation Of Folate Receptor Targeted Therapy For Treatment Of Rheumatoid Arthritis. |
DRC recommended for PrePhD |
|
18 |
Mr. Kapil Kumar Goel |
Ph.D. (Pharmaceutical Sciences) |
19-July-19 |
Dr. Rajeev Kharb |
Synthesis of Imidazoquinoxaline Based Fused Heterocycles and their Biological Assessment as anticancer agents |
Degree Awarded |